Cigna Investments’s Bruker BRKR Stock Holding History

Cigna Investments’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-50,227	Closed	-$1.5M	–	737
2018 Q1	$1.5M	Buy	50,227 +28,146	+127%	+$913K	0.1%	156
2017 Q4	$758K	Sell	22,081 -133	-0.6%	-$4.36K	0.05%	331
2017 Q3	$661K	Hold	22,214	–	–	0.04%	357
2017 Q2	$641K	Sell	22,214 -257	-1%	-$6.62K	0.04%	366
2017 Q1	$524K	Buy	22,471 +698	+3%	+$16.4K	0.04%	427
2016 Q4	$461K	Buy	+21,773	New	+$476K	0.05%	432

Other funds holding BRKR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cigna Investments's BRKR Position: Q2 2018 in Review

Cigna Investments sold out of Bruker (BRKR) in Q2 2018, closing a stake of 50,227 shares — an estimated $1.5M sold.

Cigna Investments first reported a position in BRKR in Q4 2016 and held it in 6 quarters. The position peaked at $1.5M in Q1 2018. 227 funds tracked by Wall St. Rank hold BRKR as of Q2 2018.

Cigna Investments reported no remaining Bruker position as of Q2 2018 after selling out during the quarter.
Cigna Investments sold 50,227 Bruker shares in Q2 2018, an estimated $1.5M.
Cigna Investments first reported a position in Bruker in Q4 2016 and held it in 6 quarters.
Cigna Investments's Bruker position peaked at $1.5M in Q1 2018.
227 funds tracked by Wall St. Rank held Bruker as of Q2 2018.

Based on Cigna Investments's 13F filing for Q2 2018, filed 14 Aug 2018.